Severe Eosinophilic Asthma

DrugDrug NameDrug Description
DB12023BenralizumabA monoclonal antibody used to treat eosinophilic asthma.
DB06612MepolizumabA fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome.
DB06602ReslizumabAn IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults.
DrugDrug NamePhaseStatusCount
DB11900OC-4592Completed1
DB12023Benralizumab4Active Not Recruiting1
DB12023Benralizumab4Unknown Status1
DB01222Budesonide4Active Not Recruiting1
DB00983Formoterol4Active Not Recruiting1
DB01001Salbutamol4Active Not Recruiting1
DB06612MepolizumabNot AvailableRecruiting1